Nuclear Factor Kappa B

nuclear factor kappa light chain enhancer of activated B cells

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.

The purpose of this study was to evaluate the effect of gliclazide on oxidative stress, inflammation, and bone loss in experimental periodontal disease model.Male albino Wistar rats were divided into no binder, binder, and a ligature with 1, 5, and 10 mg / kg of gliclazide group , Maxillary fixed and scanned using micro-computed tomography to measure linear and bone volume / tissue volume (BV / TV) and volumetric bone loss.

Histopathology, the analysis of immunohistochemistry and immunofluorescence performed to test the matrix metalloproteinase-2 (MMP-2), cyclooxygenase 2 (COX-2), cathepsin K, member activator receptor nuclear factor kappa-Β ligand (RANKL), an activator receptor nuclear factor kappa-Β (RANK), osteoprotegerin (OPG) pathway, the migration of macrophage inhibitory factor (MIF), superoxide dismutase-1 (SOD-1), glutathione peroxidase-1 (GPx-1), NFkB p 50 (cytoplasm), NLS NFkB p50 (signal nuclear localization), PI3 kinase and AKT staining. Myeloperoxidase activity, malondialdehyde and glutathione levels, while interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) levels were evaluated by ultraviolet-visible spectroscopy analysis.

A reverse transcription quantitative polymerase chain reaction was used to measure gene expression of nuclear factor kappa B subunit p50 (NF-kB p50), phosphoinositide 3-kinase (PI3K), protein kinase B (AKT) and F4 / 80.Micro tomography -computed showed that 1 mg / kg of gliclazide treatment reduces bone loss is linear compared with a ligature, 5 mg / kg of gliclazide, and 10 mg / kg of gliclazide treatment.

All concentrations of gliclazide increase bone volume / tissue volume (BV / TV) compared with a binder. Treatment with 1 mg / kg of gliclazide reduce myeloperoxidase activity, malondialdehyde, IL-1β and TNF-α levels (P ≤ 0.05), and results in weak staining for COX-2, cathepsin K, MMP-2, RANK, RANKL , -1 SOD, GPx-1, MIF and PI3K. Furthermore, down-regulation of NF-kB p50, PI3K, Akt, and F4 / 80 were observed, and OPG strong staining after treatment 1 mg / kg of gliclazide treatment.This decreased migration of neutrophils and macrophages, decreased inflammatory response, and decreased bone loss in rats with ligature-induced periodontitis.

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.
Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.

Preventing gliclazide 5-FU-Induced Oral Mucositis by Reducing Oxidative Stress, Inflammation, and P-Selectin Adhesion Molecules.

Oral mucositis (OM) is one of the main side effects of the treatment of head and neck cancers, particularly radiotherapy and / or chemotherapy. OM is characterized by ulcers, erythema, dysphagia, xerostomia, and increased susceptibility to opportunistic infections. In the perspective of finding a pharmacological therapy to prevent inflammation and ulceration of the OM, the investigation of the pleiotropic effects of commercial drugs are needed, including gliclazide, antidiabetic drugs.

This study aimed to evaluate the effect of gliclazide in experimental models of OM induced by 5-fluorouracil. male hamster pre-treated with oral gliclazide (1, 5, or 10 mg / kg) for 10 days. Cheek pouch samples were subjected to histopathological and immunohistochemical analysis (COX2, iNOS, MMP-2, NF P65, GPx) and imunofluorescence (P-selectin). IL-1β and TNF-α levels, Myeloperoxidase activity (MPO) and the level of malondialdehyde (MDA) was investigated by ultraviolet-visible spectroscopy analysis.

Anti-NFKB p50 (NFKB1) Antibody

GWB-CC6745 100 ul Ask for price

NFKB1 antibody

10R-11003 100 ug
EUR 344
Description: Mouse monoclonal NFKB1 antibody

NFKB1 antibody

10R-11155 100 ug
EUR 344
Description: Mouse Monoclonal NFKB1 antibody

NFKB1 antibody

20-PR03 100 ul Ask for price
Description: Rabbit polyclonal NFKB1 antibody

NFKB1 Antibody

35588 100ul
EUR 319

NFKB1 Antibody

35588-100ul 100ul
EUR 302.4

NFKB1 antibody

39087 100ul
EUR 439

NFKB1 antibody

39087-100ul 100ul
EUR 302.4

NFKB1 Antibody

E035588 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFKB1 Antibody

E10-30224 100μg/100μl
EUR 225
Description: Available in various conjugation types.

NFKB1 Antibody

E10-30234 100μg/100μl
EUR 225
Description: Available in various conjugation types.

NFKB1 Antibody

1-CSB-PA020085
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody

1-CSB-PA020086
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/5000

NFKB1 Antibody

1-CSB-PA020090
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody

1-CSB-PA020096
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody

1-CSB-PA015759GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

NFKB1 antibody

E39-05702 100ug/100ul
EUR 225
Description: Available in various conjugation types.

NFKB1 antibody

E39-05703 100ug/100ul
EUR 225
Description: Available in various conjugation types.

NFKB1 antibody

E39-10334 100ug/100ul
EUR 225
Description: Available in various conjugation types.

NFKB1 Antibody

E911160 100ul
EUR 255
Description: Available in various conjugation types.

NFKB1 Antibody

E96667 100ul
EUR 255
Description: Available in various conjugation types.

NFKB1 Antibody

E300225 200ul
EUR 275
Description: Available in various conjugation types.

NFKB1 Antibody

BF0466-100ul 100ul
EUR 350

NFKB1 Antibody

BF0466-200ul 200ul
EUR 450

NFKB1 Antibody

BF0466-50ul 50ul
EUR 250

NFKB1 antibody

70R-15433 100 ug
EUR 302
Description: Rabbit polyclonal NFKB1 antibody

NFKB1 antibody

70R-10525 50 ug
EUR 467
Description: Affinity purified rabbit polyclonal NFKB1 antibody

NFKB1 antibody

70R-18860 50 ul
EUR 289
Description: Rabbit polyclonal NFKB1 antibody

NFKB1 Antibody

1-CSB-PA004763
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

NFKB1 Antibody

1-CSB-PA003430
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.ELISA:1/10000

NFKB1 Antibody

1-CSB-PA003431
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

NFKB1 Antibody

1-CSB-PA003434
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

NFKB1 Antibody

1-CSB-PA259078
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:500-1:5000, IHC:1:5-1:20

NFKB1 Antibody

1-CSB-PA10354A0Rb
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF, ChIP; Recommended dilution: WB:1:500-1:5000, IHC:1:100-1:500, IF:1:50-1:500

NFKB1 Antibody

1-CSB-PA441503
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:1000-1:2000, WB:1:200-1:1000

NFKB1 Antibody

1-CSB-PA546304
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:500-1:5000, IHC:1:25-1:100

NFKB1 Antibody

F47079-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.

NFKB1 Antibody

F54028-0.1ML 0.1 ml
EUR 322.15
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. [UniProt]

NFKB1 Antibody

F52441-0.4ML 0.4 ml
EUR 330.65
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NFkB is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NFkB complexes are held in the cytoplasm in an inactive state complexed with members of the NFkB inhibitor (I-kappa-B) family. In a conventional activation pathway, IkB is phosphorylated by IkB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NFkB complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NFkB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NFkB proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.

NFKB1 Antibody

GWB-MX421G 50ug Ask for price

NFKB1 Antibody

GWB-DB75B4 0.05 mg Ask for price

NFKB1 Antibody

R20321-0.1ML 100ul
EUR 347.65
Description: This antibody reacts to human nuclear factor-kappa-B p105 subunit and p50 subunit.

NFKB1 Antibody

R31224 100 ug
EUR 356.15
Description: Nuclear factor NF-kappa-B p105/p50, also called EBP-1 is a protein that in humans is encoded by the NFKB1 gene. By fluorescence in situ hybridization, the gene was assigned to human chromosome 4q24. NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing.

NFKB1 antibody

BF0466 100ug
EUR 355

NFKB1 Antibody

MBS7119961-005mg 0.05mg
EUR 150

NFKB1 Antibody

MBS7119961-01mg 0.1mg
EUR 190

NFKB1 Antibody

MBS7119961-5x01mg 5x0.1mg
EUR 845

NFKB1 Antibody

MBS7119962-005mg 0.05mg
EUR 150

NFKB1 Antibody

MBS7119962-01mg 0.1mg
EUR 190

NFKB1 Antibody

MBS7119962-5x01mg 5x0.1mg
EUR 845

NFKB1 Antibody

MBS7119963-005mg 0.05mg
EUR 150

NFKB1 Antibody

MBS7119963-01mg 0.1mg
EUR 190

NFKB1 Antibody

MBS7119963-5x01mg 5x0.1mg
EUR 845

NFKB1 Antibody

MBS7119964-005mg 0.05mg
EUR 150

NFKB1 Antibody

MBS7119964-01mg 0.1mg
EUR 190

NFKB1 Antibody

MBS7119964-5x01mg 5x0.1mg
EUR 845

NFKB1 Antibody

MBS7122210-005mg 0.05mg
EUR 150

NFKB1 Antibody

MBS7122210-01mg 0.1mg
EUR 190

NFKB1 Antibody

MBS7122210-5x01mg 5x0.1mg
EUR 845

NFKB1 Antibody

MBS7122211-005mg 0.05mg
EUR 150

NFKB1 Antibody

MBS7122211-01mg 0.1mg
EUR 190

NFKB1 Antibody

MBS7122211-5x01mg 5x0.1mg
EUR 845

NFKB1 Antibody

MBS7116704-005mg 0.05mg
EUR 150

NFKB1 Antibody

MBS7116704-01mg 0.1mg
EUR 190

NFKB1 Antibody

MBS7116704-5x01mg 5x0.1mg
EUR 845

NFKB1 Antibody

MBS7117358-005mg 0.05mg
EUR 150

NFKB1 Antibody

MBS7117358-01mg 0.1mg
EUR 190

NFKB1 Antibody

MBS7117358-5x01mg 5x0.1mg
EUR 845

NFKB1 Antibody

MBS7123197-005mL 0.05mL
EUR 190

NFKB1 Antibody

MBS7123197-01mL 0.1mL
EUR 270

NFKB1 Antibody

MBS7123197-5x01mL 5x0.1mL
EUR 1205

NFKB1 Antibody

MBS7123198-005mL 0.05mL
EUR 190

NFKB1 Antibody

MBS7123198-01mL 0.1mL
EUR 270

NFKB1 Antibody

MBS7123198-5x01mL 5x0.1mL
EUR 1205

NFKB1 Antibody

MBS7123199-005mL 0.05mL
EUR 190

NFKB1 Antibody

MBS7123199-01mL 0.1mL
EUR 270

NFKB1 Antibody

MBS7123199-5x01mL 5x0.1mL
EUR 1205

NFKB1 antibody

MBS9403436-005mL 0.05mL
EUR 300

NFKB1 antibody

MBS9403436-01mL 0.1mL
EUR 390

NFKB1 antibody

MBS9403436-5x01mL 5x0.1mL
EUR 1610

NFKB1 Antibody

MBS9411643-01mL 0.1mL
EUR 305

NFKB1 Antibody

MBS9411643-5x01mL 5x0.1mL
EUR 1230

NFKB1 Antibody

MBS9200272-008mL 0.08mL
EUR 210

NFKB1 Antibody

MBS9200272-04mL 0.4mL
EUR 430

NFKB1 Antibody

MBS9200272-5x04mL 5x0.4mL
EUR 1910

NFKB1 Antibody

MBS850572-01mg 0.1mg
EUR 305

NFKB1 Antibody

MBS850572-01mLAF405L 0.1mL(AF405L)
EUR 565

NFKB1 Antibody

MBS850572-01mLAF405S 0.1mL(AF405S)
EUR 565

NFKB1 Antibody

MBS850572-01mLAF610 0.1mL(AF610)
EUR 565

NFKB1 Antibody

MBS850572-01mLAF635 0.1mL(AF635)
EUR 565

NFKB1 Antibody

MBS850916-01mg 0.1mg
EUR 305

NFKB1 Antibody

MBS850916-01mLAF405L 0.1mL(AF405L)
EUR 565

NFKB1 Antibody

MBS850916-01mLAF405S 0.1mL(AF405S)
EUR 565

NFKB1 Antibody

MBS850916-01mLAF610 0.1mL(AF610)
EUR 565

NFKB1 Antibody

MBS850916-01mLAF635 0.1mL(AF635)
EUR 565

NFKB1 antibody

MBS535040-INQUIRE INQUIRE Ask for price

NFKB1 Antibody

MBS9602664-005mL 0.05mL
EUR 260

NFKB1 Antibody

MBS9602664-01mL 0.1mL
EUR 325

NFKB1 Antibody

MBS9602664-02mL 0.2mL
EUR 400

NFKB1 Antibody

MBS9602664-5x02mL 5x0.2mL
EUR 1750

NFKB1 antibody

PAab10143 100ug
EUR 375

Anti-NFkB p105/p50/NFKB1 Antibody

PB9149 100ug/vial
EUR 400.8

Anti-NFkB p105/p50/NFKB1 Antibody

PA2111 100ug/vial
EUR 352.8

Anti-NFkB p105/p50/NFKB1 Antibody

PA2111-1 100ug/vial
EUR 352.8

NFKB1 antibody (HRP)

60R-2109 100 ug
EUR 302
Description: Rabbit polyclonal NFKB1 antibody (HRP)

NFKB1 antibody (FITC)

60R-2110 100 ug
EUR 302
Description: Rabbit polyclonal NFKB1 antibody (FITC)

NFKB1 Antibody (p105)

F47079-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.

NFKB1 Antibody (p105)

F52441-0.08ML 0.08 ml
EUR 140.25
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NFkB is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NFkB complexes are held in the cytoplasm in an inactive state complexed with members of the NFkB inhibitor (I-kappa-B) family. In a conventional activation pathway, IkB is phosphorylated by IkB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NFkB complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NFkB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NFkB proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.

NFKB1 Antibody Pair

MBS7041956-1PairSufficientfor5x96wellplates 1Pair(Sufficientfor5x96wellplates)
EUR 780

NFKB1 Antibody Pair

MBS7041956-5x1PairSufficientfor25x96wellplates 5x1Pair(Sufficientfor25x96wellplates)
EUR 3465

NFKB1 Antibody (S932)

MBS9217114-008mL 0.08mL
EUR 210

NFKB1 Antibody (S932)

MBS9217114-04mL 0.4mL
EUR 430

NFKB1 Antibody (S932)

MBS9217114-5x04mL 5x0.4mL
EUR 1910

NFKB1 antibody (biotin)

60R-2111 100 ug
EUR 302
Description: Rabbit polyclonal NFKB1 antibody (biotin)

anti- NFKB1,p105,p50-Specific antibody

FNab05704 100µg
EUR 702
Description: Antibody raised against NFKB1,p105,p50-Specific

NFKB1/P50 Antibody

MBS853649-01mLAF405L 0.1mL(AF405L)
EUR 565

NFKB1/P50 Antibody

MBS853649-01mLAF405S 0.1mL(AF405S)
EUR 565

NFKB1/P50 Antibody

MBS853649-01mLAF610 0.1mL(AF610)
EUR 565

NFKB1/P50 Antibody

MBS853649-01mLAF635 0.1mL(AF635)
EUR 565

NFKB1/P50 Antibody

MBS853649-02mL 0.2mL
EUR 345

NFKB1 (pS337) Antibody

20-abx000177
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS927) Antibody

20-abx000315
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS893) Antibody

20-abx000462
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS907) Antibody

20-abx000463
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS932) Antibody

20-abx000464
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS337) Antibody

abx000177-100l 100 µl
EUR 475

NFKB1 (pS337) Antibody

abx000177-20l 20 µl
EUR 200

NFKB1 (pS337) Antibody

abx000177-50l 50 µl
EUR 325

NFKB1 (pS927) Antibody

abx000315-100l 100 µl
EUR 475

NFKB1 (pS927) Antibody

abx000315-20l 20 µl
EUR 200

NFKB1 (pS927) Antibody

abx000315-50l 50 µl
EUR 325

NFKB1 (pS893) Antibody

abx000462-100l 100 µl
EUR 618.75

NFKB1 (pS893) Antibody

abx000462-20l 20 µl
EUR 325

NFKB1 (pS893) Antibody

abx000462-50l 50 µl
EUR 475

NFKB1 (pS907) Antibody

abx000463-100l 100 µl
EUR 618.75

NFKB1 (pS907) Antibody

abx000463-20l 20 µl
EUR 325

NFKB1 (pS907) Antibody

abx000463-50l 50 µl
EUR 475

NFKB1 (pS932) Antibody

abx000464-100l 100 µl
EUR 618.75

NFKB1 (pS932) Antibody

abx000464-20l 20 µl
EUR 325

NFKB1 (pS932) Antibody

abx000464-50l 50 µl
EUR 475

NFKB1 Polyclonal Antibody

A68309
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

NFKB1 Polyclonal Antibody

E914754 100ul
EUR 225
Description: Available in various conjugation types.

NFKB1 Conjugated Antibody

C39087 100ul
EUR 476.4

NFKB1 Conjugated Antibody

C35588 100ul
EUR 476.4

NFKB1 Polyclonal Antibody

A71337 50 μl
EUR 408

NFKB1 Polyclonal Antibody

A71338 50 μl
EUR 408

NLS NF P50 protein levels were analyzed by western blotting. The group treated with gliclazide at a dose of 10 mg / kg showed the presence of erythema, there was no evidence of erosion, and the absence of mucosal ulceration with a score of 1 (1-2) (p <0.01).

Recent Posts

Tags

May 2024
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Categories

Pages